Click here to view the Pharmaceutical Technology EuropeTM September/October 2025 issue.
Resilience and Precision in Pharma Development
Success depends on collaboration, resilience, and a focus on improving outcomes for patients worldwide.
European Union Life Science Strategy
The European Union aims to become the most attractive place for life science by 2030.
Competition in MASH Is Heating Up as GLP-1s Gate-Crash the Party
Novo Nordisk’s Wegovy will be competing with Madrigal Pharmaceuticals’ Rezdiffra in the metabolic dysfunction-associated steatohepatitis arena.
